vs

Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

APOGEE ENTERPRISES, INC. is the larger business by last-quarter revenue ($348.6M vs $270.8M, roughly 1.3× HUTCHMED (China) Ltd). APOGEE ENTERPRISES, INC. runs the higher net margin — 4.7% vs 0.7%, a 4.0% gap on every dollar of revenue. On growth, APOGEE ENTERPRISES, INC. posted the faster year-over-year revenue change (2.1% vs -16.5%). APOGEE ENTERPRISES, INC. produced more free cash flow last quarter ($22.9M vs $3.4M).

Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

APOG vs HCM — Head-to-Head

Bigger by revenue
APOG
APOG
1.3× larger
APOG
$348.6M
$270.8M
HCM
Growing faster (revenue YoY)
APOG
APOG
+18.7% gap
APOG
2.1%
-16.5%
HCM
Higher net margin
APOG
APOG
4.0% more per $
APOG
4.7%
0.7%
HCM
More free cash flow
APOG
APOG
$19.5M more FCF
APOG
$22.9M
$3.4M
HCM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
APOG
APOG
HCM
HCM
Revenue
$348.6M
$270.8M
Net Profit
$16.5M
$2.0M
Gross Margin
23.8%
37.7%
Operating Margin
7.1%
-13.2%
Net Margin
4.7%
0.7%
Revenue YoY
2.1%
-16.5%
Net Profit YoY
-21.2%
-83.6%
EPS (diluted)
$0.77
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APOG
APOG
HCM
HCM
Q4 25
$348.6M
$270.8M
Q3 25
$358.2M
Q2 25
$346.6M
$277.7M
Q1 25
$345.7M
$324.5M
Q4 24
$341.3M
Q3 24
$342.4M
Q2 24
$331.5M
$305.7M
Q1 24
$361.8M
Net Profit
APOG
APOG
HCM
HCM
Q4 25
$16.5M
$2.0M
Q3 25
$23.6M
Q2 25
$-2.7M
$455.0M
Q1 25
$2.5M
$11.9M
Q4 24
$21.0M
Q3 24
$30.6M
Q2 24
$31.0M
$25.8M
Q1 24
$15.7M
Gross Margin
APOG
APOG
HCM
HCM
Q4 25
23.8%
37.7%
Q3 25
23.1%
Q2 25
21.7%
0.1%
Q1 25
21.6%
48.0%
Q4 24
26.1%
Q3 24
28.4%
Q2 24
29.8%
41.1%
Q1 24
24.4%
Operating Margin
APOG
APOG
HCM
HCM
Q4 25
7.1%
-13.2%
Q3 25
7.5%
Q2 25
2.0%
-1.3%
Q1 25
1.8%
-5.0%
Q4 24
8.4%
Q3 24
12.3%
Q2 24
12.5%
-9.0%
Q1 24
6.0%
Net Margin
APOG
APOG
HCM
HCM
Q4 25
4.7%
0.7%
Q3 25
6.6%
Q2 25
-0.8%
163.8%
Q1 25
0.7%
3.7%
Q4 24
6.1%
Q3 24
8.9%
Q2 24
9.4%
8.4%
Q1 24
4.3%
EPS (diluted)
APOG
APOG
HCM
HCM
Q4 25
$0.77
$0.00
Q3 25
$1.10
Q2 25
$-0.13
$0.52
Q1 25
$0.12
$0.01
Q4 24
$0.96
Q3 24
$1.40
Q2 24
$1.41
$0.03
Q1 24
$0.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APOG
APOG
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$41.3M
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$512.3M
$1.2B
Total Assets
$1.1B
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APOG
APOG
HCM
HCM
Q4 25
$41.3M
$1.4B
Q3 25
$39.5M
Q2 25
$32.8M
$1.4B
Q1 25
$41.4M
$836.1M
Q4 24
$43.9M
Q3 24
$51.0M
Q2 24
$30.4M
$802.5M
Q1 24
$37.2M
Total Debt
APOG
APOG
HCM
HCM
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$285.0M
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
$62.0M
Stockholders' Equity
APOG
APOG
HCM
HCM
Q4 25
$512.3M
$1.2B
Q3 25
$500.2M
Q2 25
$481.8M
$1.2B
Q1 25
$487.9M
$759.9M
Q4 24
$522.1M
Q3 24
$506.4M
Q2 24
$480.0M
$740.1M
Q1 24
$471.0M
Total Assets
APOG
APOG
HCM
HCM
Q4 25
$1.1B
$1.8B
Q3 25
$1.2B
Q2 25
$1.2B
$1.8B
Q1 25
$1.2B
$1.3B
Q4 24
$1.2B
Q3 24
$917.1M
Q2 24
$889.0M
$1.3B
Q1 24
$884.1M
Debt / Equity
APOG
APOG
HCM
HCM
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.58×
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APOG
APOG
HCM
HCM
Operating Cash FlowLast quarter
$29.3M
$8.2M
Free Cash FlowOCF − Capex
$22.9M
$3.4M
FCF MarginFCF / Revenue
6.6%
1.2%
Capex IntensityCapex / Revenue
1.9%
1.8%
Cash ConversionOCF / Net Profit
1.77×
4.21×
TTM Free Cash FlowTrailing 4 quarters
$67.4M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APOG
APOG
HCM
HCM
Q4 25
$29.3M
$8.2M
Q3 25
$57.1M
Q2 25
$-19.8M
$-72.9M
Q1 25
$30.0M
$40.3M
Q4 24
$31.0M
Q3 24
$58.7M
Q2 24
$5.5M
$-39.8M
Q1 24
$74.9M
Free Cash Flow
APOG
APOG
HCM
HCM
Q4 25
$22.9M
$3.4M
Q3 25
$52.4M
Q2 25
$-26.9M
$-82.2M
Q1 25
$19.1M
$32.5M
Q4 24
$22.0M
Q3 24
$50.2M
Q2 24
$-1.8M
$-49.9M
Q1 24
$58.7M
FCF Margin
APOG
APOG
HCM
HCM
Q4 25
6.6%
1.2%
Q3 25
14.6%
Q2 25
-7.8%
-29.6%
Q1 25
5.5%
10.0%
Q4 24
6.4%
Q3 24
14.7%
Q2 24
-0.5%
-16.3%
Q1 24
16.2%
Capex Intensity
APOG
APOG
HCM
HCM
Q4 25
1.9%
1.8%
Q3 25
1.3%
Q2 25
2.1%
3.3%
Q1 25
3.2%
2.4%
Q4 24
2.6%
Q3 24
2.5%
Q2 24
2.2%
3.3%
Q1 24
4.5%
Cash Conversion
APOG
APOG
HCM
HCM
Q4 25
1.77×
4.21×
Q3 25
2.41×
Q2 25
-0.16×
Q1 25
12.08×
3.38×
Q4 24
1.48×
Q3 24
1.92×
Q2 24
0.18×
-1.54×
Q1 24
4.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APOG
APOG

Transferred At Point In Time$163.0M47%
Architectural Services Segment$105.2M30%
Performance Surfaces$53.0M15%
UW Interco LLC$27.9M8%

HCM
HCM

Segment breakdown not available.

Related Comparisons